Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03071172
Recruitment Status : Unknown
Verified February 2017 by GeneScience Pharmaceuticals Co., Ltd..
Recruitment status was:  Not yet recruiting
First Posted : March 6, 2017
Last Update Posted : March 6, 2017
Sponsor:
Collaborators:
Peking University Third Hospital
The First Affiliated Hospital with Nanjing Medical University
Women's Hospital School Of Medicine Zhejiang University
Xiangya Hospital of Central South University
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
The First Affiliated Hospital of Anhui Medical University
Information provided by (Responsible Party):
GeneScience Pharmaceuticals Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : May 2018